Clinical Trial Update: Evaluation of the Value of 18F-Fluoromisonidazole (18F-FMISO) Positron Emission Tomography Hypoxia Imaging in Idiopathic Pulmonary Fibrosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update indicating completion of a study evaluating 18F-FMISO PET hypoxia imaging in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• 18F-Fluoromisonidazole (18F-fluoromisonidazole)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED